期刊
ANTIOXIDANTS
卷 12, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/antiox12030584
关键词
advanced glycation end products (AGEs); aging; cardiovascular diseases; chronic kidney disease (CKD); inflammation; mortality; pro-oxidant milieu; sarcopenia
Advanced glycation end products (AGEs) are aging products that accumulate in chronic kidney disease (CKD) due to increased production, reduced excretion, and imbalance between oxidant/antioxidant capacities. This review aims to summarize the knowledge of AGEs in CKD onset and progression, focusing on related disorders and mortality. The role of AGEs as etiopathogenetic molecules and potential markers or therapeutic targets will be discussed.
Advanced glycation end products (AGEs) are aging products. In chronic kidney disease (CKD), AGEs accumulate due to the increased production, reduced excretion, and the imbalance between oxidant/antioxidant capacities. CKD is therefore a model of aging. The aim of this review is to summarize the present knowledge of AGEs in CKD onset and progression, also focusing on CKD-related disorders (cardiovascular diseases, sarcopenia, and nutritional imbalance) and CKD mortality. The role of AGEs as etiopathogenetic molecules, as well as potential markers of disease progression and/or therapeutic targets, will be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据